Hybrid PET/MRI of intracranial masses: Initial experiences and comparison to PET/CT

Journal of Nuclear Medicine

Volumn 51, Issue 8, 2010, Pages 1198-1205

  Boss, Andreas ^a   Bisdas, Sotirios ^a   Kolb, Armin ^a   Hofmann, Matthias ^a,b   Ernemann, Ulrike ^a   Claussen, Claus D ^a   Pfannenberg, Christina ^a   Pichler, Bernd J ^a   Reimold, Matthias ^a   Stegger, Lars ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOLOGICAL CYBERNETICS   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

DOTATOC; Hybrid imaging; Intracranial tumor; Methionine; PET MRI

Indexed keywords

IOPROMIDE; (DOTA(0) PHE(1) TYR(3))OCTREOTIDE; (DOTA(0)-PHE(1)-TYR(3))OCTREOTIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GALLIUM; METHIONINE; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG HALF LIFE; GLIOBLASTOMA; GLIOMA; GRAY MATTER; HUMAN; HUMAN TISSUE; INTRACRANIAL TUMOR; MENINGIOMA; NEUROEPITHELIOMA; NOSE MUCOSA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIGNAL NOISE RATIO; TUMOR BIOPSY; TWO HYBRID SYSTEM; WHITE MATTER; BRAIN TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; IMAGE PROCESSING; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PILOT STUDY; SCINTISCANNING; STATISTICAL ANALYSIS;

ADULT; AGED; BRAIN NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; GALLIUM RADIOISOTOPES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; OCTREOTIDE; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 77956216707     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.074773     Document Type: Article

References (23)

1. Price SJ. The role of advanced MR imaging in understanding brain tumour pathology. Br J Neurosurg. 2007;21:562-575.
2. Lunsford LD, Martinez AJ, Latchaw RE. Magnetic resonance imaging does not define tumor boundaries. Acta Radiol Suppl. 1986;369:154-156.
3. Johnson PC, Hunt SJ, Drayer BP. Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. Radiology. 1989;170:211-217.
4. Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg. 1993;79:533-536.
5. Scott JN, Brasher PMA, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology. 2002;59:947-949.
6. Khayal IS, McKnight TR, McGue C, et al. Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas. NMR Biomed. 2009;22:449-455.
7. Noguchi T, Yoshiura T, Hiwatashi A, et al. Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR. 2008;29:688-693.
8. 1H magnetic resonance spectroscopy. Surg Neurol. 1995;44:137-144.
9. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg. 1996;84:449-458. (Pubitemid 26062870)
10. Langen K-J, Tatsch K, Grosu A-L, Jacobs AH, Weckesser M, Sabri O. Diagnostics of cerebral gliomas with radiolabeled amino acids. Dtsch Arztebl Int. 2008;105:55-61.
11. 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas. J Nucl Med. 2005;46:763-769.
12. Khan MU, Khan S, El-Refaie S, Win Z, Rubello D, Al-Nahhas A. Clinical indications for Gallium-68 positron emission tomography imaging. Eur J Surg Oncol. 2009;35:561-567.
13. 68Ga]- DOTATOC-PET. Int J Radiat Oncol Biol Phys. 2006;65:222-227.
14. 68Ga]-DOTA-D Phe1-Tyr3-octreotide (DOTA-TOC): first results in meningioma-patients. J Nucl Med. 2001;42:1053-1056.
15. Ullrich RT, Kracht LW, Jacobs AH. Neuroimaging in patients with gliomas. Semin Neurol. 2008;28:484-494.
16. Shao Y, Cherry S, Farahani K, et al. Development of a PET detector system compatible with MRI/NMR systems. IEEE Trans Nucl Sci. 1997;44:1167-1171.
17. Pichler B, Lorenz E, Mirzoyan R, et al. Performance test of a LSO-APD PET module in a 9.4 Tesla magnet. IEEE Nucl Sci Symp. 1997;2:1237-1239.
18. Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14:459-465.
19. Schlemmer HP, Pichler BJ, Schmand M, et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology. 2008;248:1028-1035.
20. Comtat C, Bataille F, Michel C, et al. OSEM-3D reconstruction strategies for the ECAT HRRT. IEEE Nucl Sci Symp Conf Rec. 2004;6:3492-3496. (Pubitemid 41147700)
21. Hofmann M, Steinke F, Scheel V, et al. MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med. 2008;49:1875-1883.
22. Vollmar S, Hampl JA, Kracht L, et al. Integration of functional data (PET) into brain surgery planning and neuronavigation. In: Buzug TM, ed. Advances in Medical Engineering: Proceedings in Physics 114. Berlin, Germany: Springer; 2007:98-103.
23. 11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med. 1997;38:517-522.